导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.72% | 2393/4773 |
| 近一周 | -2.20% | 1477/5462 |
| 近一月 | -3.95% | 2099/5421 |
| 近一季 | -6.62% | 2152/5209 |
| 近半年 | -1.74% | 1682/4920 |
| 近一年 | 1.90% | 2243/4366 |
| 近两年 | 44.31% | 1673/2954 |
| 近三年 | 26.73% | 1196/2253 |
| 成立以来 | 321.93% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.44% 3209/4961 |
12.41% 2183/5312 |
- - |
- - |
| 2025 | 19.31% 2229/4813 |
-0.94% 2479/3635 |
2.13% 1832/4076 |
17.61% 2465/4524 |
0.27% 2092/4813 |
| 2024 | 15.02% 974/3463 |
2.80% 695/2808 |
-1.20% 977/3014 |
15.66% 1660/3129 |
-2.08% 1950/3463 |
| 2023 | -8.99% 1085/2656 |
4.23% 1010/2280 |
-3.80% 908/2385 |
-2.91% 789/2515 |
-6.52% 1808/2655 |
| 2022 | -18.28% 683/2207 |
-13.54% 777/1919 |
6.68% 634/2016 |
-13.38% 894/2113 |
2.28% 992/2208 |
| 2021 | -1.48% 803/1822 |
-1.56% 513/1255 |
3.16% 979/1330 |
-4.76% 734/1466 |
1.86% 773/1822 |
| 2020 | 29.69% 532/1250 |
-8.41% 608/1028 |
12.60% 678/1067 |
12.94% 353/1164 |
11.35% 549/1184 |
| 2019 | 33.89% 420/1092 |
26.66% 386/754 |
-1.88% 330/804 |
0.63% 500/850 |
7.06% 494/918 |
| 2018 | -23.46% 280/834 |
- - |
- - |
- - |
-11.96% 387/691 |
| 2017 | 19.34% 195/714 |
- - |
- - |
- - |
- - |
| 2016 | -9.60% 266/605 |
- - |
- - |
- - |
- - |
| 2015 | 7.99% 173/575 |
- - |
- - |
- - |
- - |
| 2014 | 49.51% 88/237 |
- - |
- - |
- - |
- - |
| 2013 | -5.51% 99/186 |
- - |
- - |
- - |
- - |
| 2012 | 8.48% 53/140 |
- - |
- - |
- - |
- - |
| 2011 | -23.76% 66/102 |
- - |
- - |
- - |
- - |
| 2010 | -12.44% 35/58 |
- - |
- - |
- - |
- - |
| 2009 | 90.08% 8/27 |
- - |
- - |
- - |
- - |
| 2008 | -64.77% 24/26 |
- - |
- - |
- - |
- - |
| 2007 | 132.18% 15/22 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 大成沪深300指数A VS. 长安沪深300非周期A(740101) |